1. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]-indene-3-acetic acid in the rat, dog, rhesus monkey, and man;Hucker;Drug Metab Dispos,1973
2. Identification of the biologically active form of sulindac;Duggan;J Pharmacol Exp Ther,1977
3. Initial clinical studies of the bioactive sulfide metabolite of sulindac;Swanson;Clin Res,1982
4. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac;Sitar;Clin Pharmacol Ther,1985
5. Effects of age and renal function on sulindac disposition in humans;Hall;FASEB J,1993